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Abstract 
It is commonly believed that people perform less 
efficiently when suffering from viral illnesses such as 
colds or influenza, but there is a scarcity of both 
conclusive research and replicated data providing 
scientific evidence for this. The current review gives an 
appraisal of research into the cognitive effects of viral 
illnesses and their implications for future research into 
the hepatitis C virus (HCV), which has been neglected so 
far in the behavioural virology area. The natural history 
and aetiology of HCV, including coverage of modes of 
transmission for chronic and acute HCV and their 
implications for experimental investigations are also 
discussed. Finally, there is a summary detailing the 
importance of behavioural research into HCV and providing 
suggestions for future studies in the area. 
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Anyone who has suffered the misfortune of contracting 
a viral illness would be more than willing to testify to 
the fact that in addition to their physiological symptoms, 
they experience adverse effects on mood, behaviour, and 
cognition. Despite the consistent self-report of 
performing less efficiently when suffering from viral 
illnesses, little scientific evidence has been conducted to 
unequivocally support such claims (Savory, 1992). 
Particularly in the last decade or two however, an area of 
research has been developed to begin a thorough 
investigation into the effects of various viruses on mental 
functioning and behaviour, it has become known as 
Behavioural Virology. 
With the exception of a minority of individual 
researchers (Corney, Hale, & Ball, 1994; Perdices, 1994) 
the majority of behavioural virology studies have been 
conducted at the MRC Common Cold Unit in the United Kingdom 
and the Health Psychology Research Unit in Cardiff and 
Bristol and have involved a range of viruses causing 
illnesses such as influenza and Infectious Mononucleosis 
(glandular fever), but not, as yet, HCV. Experimental 
methods have often involved challenging volunteers with a 
known virus and then measuring the resulting cognitive-
behavioural performance. Up to now, research has found 
that influenza viruses, common cold viruses, Human 
Immunodeficiency Virus (HIV), and Epstein-Barr virus 
(producing glandular fever) affect mental functioning and 
behaviour in apparently distinct ways, with deficits 
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ranging from poor attention and concentration to slowed 
reaction times and motor coordination. Whether or not each 
individual virus produces a specific and discrete pattern 
of deficits that is replicable upon retesting however, has 
yet to be determined. 
The causes for these viral induced psychological 
deficits have not been clearly identified within the 
literature, however, several possible hypotheses have been 
proposed. These include that the viruses lead to muscle 
fatigue resulting in poor performance (Smith, 1993); that 
the symptomatology of each virus leads to different 
performance states (Smith, Tyrrell, Coyle & Willman, 1987); 
that an increase in the release of cytokines such as 
interleukins (IL-1), tumour necrosis factor (TNF) and alpha 
interferons by the immune system affects performance (Hart, 
1988; Hickie & Lloyd, 1995); and that the infection itself 
takes a toll on the body's overall reactions (Savory, 
1991). 
Despite these investigations, research into 
behavioural virology is only in its infancy and has 
confined its investigations to a select number of viruses. 
HCV, which is the virus causing the most concern in 
Australia at the moment, due to its high endemic rate, has 
evaded the scrutiny of the behavioural virologist. 
Interestingly, it shares some common symptomatology with 
glandular fever (mainly fever, fatigue, and possible liver 
infection) and could therefore result in a similar profile 
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of cognitive deficits. One possible reason why HCV has 
been neglected in behavioural virology research revolves 
around its association with intravenous (IV) drug use. A 
large percentage of individuals with HCV are IV users who 
contracted the virus through shared contaminated needles 
(Bell, Batey, Farrell, Crewe, Cunningham, & Byth, 1990). 
IV drug use in participants has been viewed as a 
confounding factor that would be difficult to control for 
in experimental research. 
Viral hepatitis can be simply described as '. . . 
inflammation of the liver,' caused by a '. . . tiny, 
microscopic infectious germ.' (Australian Gastroenterology 
Institute, 1991, p. 2). Currently, HCV has reached 
epidemic proportions amongst drug injecting populations in 
Australia. Bell, Batey, Farrell, Crewe, Cunningham, and 
Byth (1990) tested the blood of 172 intravenous drug users 
in South Western Sydney and found that 86% were positive 
for antibodies to HCV. Other groups showing a high 
prevalence of HCV compared to community prevalence include 
haemophiliacs (75.6%), prisoners (30.8%), and female 
prostitutes (10.4%) (Fairley, Leslie, Nicholson, & Gust, 
1990). HCV is more infectious than HIV, and can cause 
chronic ill health, cirrhosis and liver cancer. The high 
level of infection ". . . suggests public health 
authorities face a bigger challenge in controlling its 
spread than they did with HIV" (Wilson, 1993, p. 1). 
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The aims of the current review are to provide an 
accurate definition and detailed outline of HCV, including 
how both chronic and acute HCV is transmitted through 
contaminated blood products, transfusions, bodily fluids 
and person to person contact. This transmission research 
is further discussed in terms of its implications for 
experimental investigations. In addition, findings and 
critical analyses of research into the behavioural effects 
of other viral illnesses is provided and discussed in terms 
of their implications for future research into the 
hepatitis viruses. In conclusion, there is an exploration 
of the merits behavioural research into HCV would have upon 
those infected with the virus and the general community as 
a whole. Recommendations for future investigations into 
the area are also suggested. 
Definitions and Natural History. 
Testing is now available for five distinct types of 
hepatitis viruses (A, B, C, D, and E). However, 
examination of human stool samples suggest that there is 
another candidate, hepatitis F and a provisionally 
designated blood-borne hepatitis G virus. Current 
investigations suggest the alarming fact that ". . . the 
hepatitis alphabet may need to be extended even after 
inclusion of some of these new viruses" (Bowden, Moaven, & 
Locarnini, 1996, p. 87). 
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Despite the fact that hepatitis has been recognised as 
a viral infection since ancient times, there was no 
immediate evidence for the viral aetiology of hepatitis 
until the early 1940s. The major difficulties in studying 
the agent of hepatitis, during a time in which major 
discoveries in clinical virology occurred were (a) the 
inability to isolate and propagate the hepatitis viruses in 
vitro, and (b) a lack of adequate experimental animal 
models. (Zuckerman & Thomas, 1993). 
In regard to the latter point, there were several 
unsuccessful attempts to transmit hepatitis to non-human 
primates. Failure was in retrospect, attributed to the 
fact that many of the animals were already immune to the 
virus. The first successful transmission of a form of 
hepatitis infection to chimpanzees did not occur until the 
early 1970s. As a result, much of the early progress on 
the hepatitis viruses came from experimental transmission 
in human volunteers. It was from such studies that they 
were able to identify "...two antigenically distinct forms 
of viral hepatitis" (Zuckerman & Thomas, 1993, p. 241). 
Hepatitis A or 'infectious hepatitis,' possessed a 
brief incubation period of two to six weeks and was 
principally transmitted by the faecal-oral route. In 
contrast, hepatitis B or 'serum hepatitis,' had an 
extensive incubation period (six weeks to six months) and 
the primary transmission route was parenteral. 
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In 1973, it became apparent that there was a third 
type of hepatitis that had an incubation period 
intermediate to that of hepatitis A and B, it was 
designated non-A, non-B (NANB). Evidence that NANB 
hepatitis was indeed infectious came from its successful 
transmission to chimpanzees and the demonstration of serial 
transmission to other animals. The similarity between 
humans and chimpanzees in terms of their phylogenetic 
relationship, immune responses and host-pathogen 
interactions to a variety of human agents has made 
chimpanzees extremely suitable for hepatitis research. 
They are in particular a good model for NANB hepatitis 
because the development of the host immune response mimics 
very accurately the clinical and immunological observations 
in humans. From these studies emerged the discovery in 
1989 of the causative agent, it became known as the 
hepatitis C virus (Choo, Kuo, Weiner, Overby, Bradley, & 
Houghton, 1989). 
HCV is a novel agent, but closely related to both 
animal pestiviruses (eg. bovine viral diarrhoea and hog 
cholera) and to the human flaviviruses (eg. yellow fever 
and dengue fever). It is classified in the Flaviviridae 
family, but as a separate genus. HCV is now the most 
common hepatitis virus, affecting about 0.4% (1 in 250) of 
the Australian community (Australian Gastroenterology 
Institute, 1991). The mean incubation period of HCV is 10- 
12 weeks. Clinical diagnosis involves epidemiological 
history and serological confirmation showing persistent 
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elevated aminotransferases for at least six months and 
anti-HCV in the serum. 
Acute and Chronic Hepatitis C 
HCV can cause acute (short-lived) disease, which may 
resolve completely. Alternatively, in 50% of patients it 
leads to chronic hepatitis (greater than six months), with 
a predisposition towards developing cirrhosis and primary 
hepatocellular carcinoma (New South Wales Department of 
Health, 1993). 
The onset of acute HCV is insidious, with either quite 
pronounced symptomatology or no symptoms at all. Malaise, 
anorexia, nausea, and right upper quadrant pain may be 
present, and patients may also exhibit abdominal cramps, 
fever, dark urine, and a general feeling of being unwell 
(New South Wales Department of Health, 1993). In the 25% 
in whom jaundice develops, fatigue and anorexia usually 
worsen. Jaundice can last from a few days to a few months, 
but is usually less than one month. Some pruritus (violent 
itching of the skin) may occur, as well as mild weight 
loss. Fatigue usually abates after the jaundice resolves, 
but may persist for several months. Abnormal enlargement 
of liver and spleen are found in a few patients, and 
arthritis and rashes have also been reported (Zuckerman & 
Thomas, 1993). 
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Most patients who go on to develop chronic HCV are 
either mildly symptomatic or completely asymptomatic. 
Serum aminotransferases decline from the peaks of the acute 
phase, but typically remain elevated by two - eight fold. 
In symptomatic patients, fatigue is the most common 
complaint, typically accompanied by abdominal discomfort 
and nausea. With more severe disease, spider angiomata and 
hepatosplenomegaly may be found. Cirrhosis develops in 
approximately 20% of chronic patients within ten years. 
Cirrhosis is when scar tissue forms on the liver and 
prevents it from working properly. It may be indolent and 
slowly progressive over a long period, or rapidly 
progressive. Cirrhosis is often signalled by tiredness, 
jaundice, fluid retention, bruising, or bleeding. With 
cirrhosis, weakness, wasting, oedema, and abdominal dropsy 
are more common (Zuckerman & Thomas, 1993). 
When studying the behavioural effects of various 
viruses, many researchers have failed to mention whether 
they have taken into account the fact that some patients 
may be in an acute stage and some the chronic stage of the 
illness (Smith et al., 1987; Smith, Tyrrell, Al-Nakib, 
Barrow, Higgins, Leekham, & Trickett, 1989). Length of 
infection may play a significant role in whether or not 
deficits exist and the pattern of deficits that are 
discovered. Not distinguishing groups of participants in 
the chronic period from those in the acute may result in 
the failure to determine the deficits unique to each stage, 
if indeed there are any. Future research investigating 
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viruses such as HCV needs to clearly delineate which group 
they are studying (chronic or acute) and analyse and 
interpret the data for each separately. 
Transmission of HCV 
Sexual Transmission  
It is believed possible that HCV can be transmitted 
sexually, but it is an inefficient and infrequent means of 
becoming infected. The prevalence of anti-HCV tends to be 
higher among sexually promiscuous patients who admit 
intravenous drug abuse. Researchers looking for HCV in 
semen have detected it only in a minority of cases. Even 
when infection is found in two people who are in a sexual 
relationship, it is not always clear that the route of 
transmission was necessarily sexual (Tibbs, 1995). Indeed 
the current evidence for a sexual transmission route is 
mainly correlational and could therefore be coincidental or 
a result of some other extraneous factor. HIV could be 
one of these factors. For example, Eyster, Alter, Aledort, 
Quan, Hatzakis, and Goedert (1991) found that "The 
frequency of HCV transmission to sexual partners is five 
times higher when HIV is also transmitted, suggesting that 
HIV may be a cofactor for the sexual transmission of HCV" 
(pp. 764-768). 
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Maternal-Infant Transmission  
A very uncommon but possible route of transmission of 
HCV is from infected mother to the infant she is carrying. 
HCV ribonucleic acid (RNA) has been discovered in the serum 
of newborn babies delivered by women who were anti-HCV 
positive. This suggests a possible transmission route for 
HCV (Thaler, Park, & Landers, 1991). 
Community Transmission  
In some individuals infected with HCV, the only risk 
factor that can be determined is that they came from a 
region or community where the virus was fairly rampant. In 
such cases of community-acquired disease one can only 
speculate that the virus may be spread by close person to 
person contact from carriers of HCV. However, general 
rules of hygiene such as avoiding sharing razors, 
toothbrushes, and other personal items which may have 
traces of blood on them, make the risk of transmission very 
low (Wilson, 1993). Transmission by insect vectors has 
been proposed but there remains no direct evidence. 
Blood Transfusion and Blood Products  
HCV is, however, primarily contracted through blood 
transfusion or blood products that are infected with the 
virus. The highest prevalences worldwide are found in 
haemophiliacs, 50-90% of whom are anti-HCV positive. Anti-
HCV is also quite common among transplant patients needing 
frequent blood transfusions, particularly liver, renal, and 
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bone marrow transplant patients (Baur, Daniel, Pomer, 
Scheurlen, Opelz, & Roelcke, 1991). 
Health care workers also face a small occupational 
risk of contracting HCV through accidental needle-stick 
injury. The Hepatitis C Review newsletter (1996), already 
reports of health care workers who have contracted HCV 
through needle-stick injury and as a result, are unemployed 
and ". . . battling for basic workers compensation. . . " 
(p. 6). 
There is also a high incidence of hepatitis C among 
intravenous drug users (70-92%) due to repeated exposure to 
carriers of the virus through shared, contaminated needles. 
One study targeting injecting drug-users in Adelaide, 
Melbourne, Perth, and Sydney, found that of the 872 users 
surveyed, 54.8% tested positive for HCV antibodies, whereas 
only 18.9% reported having HBV and 3.1% as being HIV 
positive (De La Harpe, 1995). 
There is also documented evidence of HCV being 
transmitted by human bite as a result of saliva containing 
HCV RNA or saliva containing infected blood (Dusheiko, 
Smith, & Scheuer, 1990). 
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Implications from Transmission Studies. 
The implication for research into HCV and indeed any 
hepatitis virus, is the possible confounding variable of IV 
drug use and concurrent infection with other viruses. It 
is apparent from the transmission research, that a high 
percentage of patients infected with HCV are IV drug users. 
Patients who are continually using IV drugs would have to 
be screened out of any contemporary experiments, otherwise 
any real cognition or perceptual-motor performance deficits 
could be attributed to the effects of drugs like heroin 
rather than HCV. In contrast, previous IV drug users who 
have contracted HCV could be allowed to participate, if 
matched to controls with a similar drug history. Finally, 
there are patients who in addition to HCV are infected with 
other viruses such as HIV or Hepatitis B (HBV) because of 
the risky lifestyle they lead. These patients would also 
have to be excluded from research, as it would be 
impossible to attribute any mental performance changes 
exclusively to HCV. 
The Effect of Viral Infections Upon Cognitive and 
Motor Performance 
Behavioural virology research studies the effects of 
viruses upon cognitive functioning and behaviour. 
Currently, research has encompassed the influenza viruses, 
various common cold viruses, HIV, Epstein Barr virus, and 
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chronic fatigue syndrome, a serious illness possibly 
arising from a viral infection (Lloyd, Hickie, & Peterson, 
1997). The majority have been reported to produce a range 
of deficits in processes such as attention, reaction time, 
memory, concentration, and perceptual-motor skills. Just 
as these viruses have resulted in cognitive decrements, so 
too could HCV. However, HCV, has been ignored in this area 
of investigation, despite the virus being a major concern 
in Australia at present. 
Common Cold and Influenza Viruses  
Smith, Tyrrell, Barrow, Higgins, Bull, Trickett, and 
Wilkins (1992) investigated the common cold for pattern 
sensitivity and contrast sensitivity. In their experiments 
participants were challenged with Respiratory Syncytial 
Virus (RSV), Coronavirus, or Rhinovirus. Of those 
participants who developed a cold after exposure to RSV, 
they were found to be more sensitive to a visually 
distracting pattern presented prior to virus challenge than 
volunteers who did not get a cold. Those who developed a 
sub-clinical infection reported more illusions after virus 
challenge than they had done before, whereas uninfected 
participants and those with colds tended to report fewer 
illusions on the second test after infection. These 
effects were not found in participants challenged with 
Corona- or Rhinovirus. These results suggest that 
sensitivity to a visually disturbing pattern may be related 
to susceptibility for developing a cold from the 
Respiratory Syncytial virus. In addition, subclinical cold 
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infections (not just clinical illness) can produce 
behavioural effects. 
Smith (1992b) also reports two experiments which 
looked at the effects of experimentally induced upper 
respiratory viral infections (cold producing Rhinovirus RV9 
and Influenza A/Eng virus) on selective attention. The 
Stroop task was used to measure attention. There was no 
effect of either cold or influenza on the speed of carrying 
out the various conditions involved in the Stroop task. 
However, participants with influenza illnesses were less 
accurate at naming colours when distracting colour words 
were present. These results suggest that the effects of a 
cold and influenza are different and that an attention 
demanding task is impaired by influenza. 
Four experiments investigated the effects of 
experimentally induced colds on various aspects of memory 
of 27, 47, 39, and 30 adults (Smith, Tyrrell, Barrow, 
Coyle, Higgins, Trickett, & Willman, 1990). Participants 
were challenged with a Coronavirus or Rhinoviruses RV2, 
RV9, or RV14. A fully developed cold was found to have no 
effect upon free recall, digit span, or retrieval from 
semantic memory performance. However, immediate 
recognition of important information from a 15 minute story 
was impaired in participants with colds, which suggests 
they were less able to follow the theme of the story. 
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Smith, Thomas, Brockman, Kent, and Nicholson (1993) 
studied the effects of natural rather than experimentally 
induced Influenza B on reaction time, repeated numbers 
detection, free recall, delayed recognition memory, logical 
reasoning, focused attention, and categorical search. In 
the first experiment, there were 26 participants with 
Influenza B, who were tested when they were ill and again 
when fully recovered. Influenza B had no effect on mood or 
on performance of the five choice serial response and 
focused attention tasks and free recall, delayed 
recognition memory, and logical reasoning tests. However 
Influenza B patients had significantly longer reaction 
times compared to when they were free of viral infection, 
and were slower at repeated numbers detection and less 
accurate at categorical search. In the second experiment, 
there were 72 patients with Influenza B. Once again a 
reaction time effect was found. The Influenza B patients 
showed a 19% increase in the reaction time for the 10 
minute version of the variable fore period simple reaction 
time test when compared with controls. These findings were 
in support of Smith et al.'s (1987) earlier findings that 
Influenza B increased simple reaction time, in their 
experiment, by 57%. 
Finally, Smith et al. (1993) investigated the effects 
of naturally occurring upper respiratory tract illnesses 
(URTIs) upon real life work performance. They focussed 
upon performance efficiency, trying to establish a link 
between viral infection and the number of workplace 
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accidents. They studied 923 patients attending Accident 
and Emergency departments at a time of year when URT 
viruses were prevalent. There were no significant 
associations between URTIs and workplace accidents. 
Research clearly shows that influenza and the common 
cold produce different cognitive decrements and, within 
these broad categories, various strains of each virus also 
result in distinct impairments. Deficits range from 
increased reaction time, to significant difficulties in 
attention, and with the exception of one study (Smith et 
al., 1993), have been found in naturally occurring and 
experimentally induced viral illnesses. 
Chronic Fatigue Syndrome  
Chronic Fatigue Syndrome (CFS) has occasionally been 
found to be caused by or linked to a viral infection. For 
some years the Epstein-Barr Virus was thought to be the 
exclusive cause of CFS, a syndrome characterised by 
headaches, psychiatric symptoms such as depression, muscle 
weakness, sleep disturbance, and fatigue for at least six 
months without identifiable medical or psychiatric cause. 
This has now been dismissed and CFS has been proposed to be 
the possible result of imbalances in neurotransmitters; or 
viral factors in combination, such as retro- and 
enteroviruses (Lloyd, Hickie & Peterson, 1997). It is 
included in this review because of its possible viral 
origins and the effect it has on cognitive functioning. 
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Smith, Behan, Bell, Millar, and Bakheit (1993) 
compared 57 CFS sufferers with 19 healthy controls on a 
number of performance tests. Patients and controls were 
matched for age and education level. CFS participants were 
slower on psychomotor tasks (simple reaction time task and 
5 choice serial response task), were more visually 
sensitive than the controls, and were worse at sustaining 
attention. They were also more distracted by irrelevant 
stimuli in the Stroop task. In addition, semantic 
processing and speed of logical reasoning were also 
impaired, but digit span and free recall performance did 
not differ significantly from the controls. None of the 
performance impairments could be attributed to 
psychopathology. 
In support of these findings Daugherty, Henry, 
Peterson, Swarts, Bastien, and Thomas (1991) report that 
CFS patients exhibited deficits in attention, motor skills, 
problem solving, and visual and verbal memory. Smith 
(1992) then tested the performance of eight CFS patients 
with 23 controls on pencil and paper performance tasks. 
CFS patients were slow on a motor task (pegboard task) and 
performed visual search tasks and working and semantic 
memory tasks more slowly and less accurately than the 
controls. 
Patients with CFS are slower to react to stimuli. 
Simple reaction times have been found to be slower than 
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controls on visual and auditory discrimination tasks 
(Scheffers, Johnson, Grafman, Dale, & Straus, 1992) and in 
simple and serial reaction time tasks (Smith, 1991; Smith 
et al., 1993). Moss-Morris, Petrie, Large and Kydd,(1996), 
in their extensive review of chronic fatigue research, 
propose that these findings seem to be related to delayed 
information processing, rather than impaired motor 
responses. In two studies examining information processing 
in individuals with CFS and Multiple Sclerosis (MS), 
results indicated that CSF and MS patients showed 
significant impairments on tests of complex concentration 
when compared with appropriate controls and have difficulty 
on tasks that require simultaneous processing of complex 
cognitive information (DeLuca, Johnson, & Natelson, 1993; 
DeLuca, Johnson, Beldowicz, & Natelson, 1995). These 
studies suggest that CFS patients have a selective 
impairment in information processing efficiency. 
Not all investigators have observed decrements in 
performance of CFS patients relative to controls. Altay, 
Abbey, Toner, Salit, Brooker, and Garfinkel (1990) studied 
controls and CFS patients on a battery of 
neuropsychological tests and found that CFS patients 
performed at a significantly higher level than an age-
matched group. However, this may have simply reflected the 
fact that the patients were not matched with controls on 
educational and achievement records. Studies which have 
measured the overall intellectual functioning, have found 
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no evidence of intellectual decline or any primary deficit 
in intellectual functioning in CFS patients (Scheffers et 
al., 1992). 
There has been no clear evidence of any sensory or 
perceptual impairments (Prasher, Smith & Findley, 1990; 
Scheffers et al., 1992), and verbal attention of CFS 
patients has been found to be comparable with both 
normative data and matched controls (Moss-Morris et al., 
1996). No Magnetic Resonance Imaging or Event Related 
Potential abnormalities have been found in CFS patients 
(Scheffers et. al., 1992; Cope, Pernet, Kendall, & David, 
1995). Consequently, there is virtually no current 
evidence revealing that organic factors contribute to any 
neuropsychological impairment in CFS. 
The dilemma with this research is that CFS patients 
are usually seen many months, if not years, after the 
supposed original illness. It is therefore problematic to 
attribute fatigue related symptoms to a preceding viral 
illness, and it is difficult to determine which virus if 
any, is actually responsible for the cognitive impairments 
found in the studies of CFS patients. 
Infectious Mononucleosis (IM) or Glandular Fever  
Hall and Smith (1993) examined the effects of acute 
and chronic glandular fever (caused by the Epstein-Barr 
Virus) on memory, attention, psychomotor performance, and 
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mood. There was an acute and chronic group of participants 
and matched healthy controls. Acute IM patients had 
significantly slower reaction times than controls. Acute 
patients also had difficulties sustaining attention, making 
significantly more false alarms in the detection of 
repeated numbers task than controls. Chronic IM 
participants were significantly worse than controls at 
recalling a word list and less accurate on the logical 
reasoning task, both of which are memory tasks. None of 
the performance effects could be attributed to depression. 
The results of this study show selective effects of acute 
and chronic IM on performance. 
Corney, Hale, and Ball (1994) in a study of 16 acute 
IM patients and 16 matched controls, also found that acute 
IM participants had significantly slower reaction times 
than controls (by 28%). They also reported more illusions 
of movement and colour than controls and were 10% slower at 
logical reasoning. The logical reasoning scores however 
were at chance level and therefore probably more accurately 
reflected a slowed reaction time. Hall and Smith's (1993) 
findings of interference with attention in acute IM 
subjects was not replicated however. 
In summary, glandular fever has been found to affect 
memory, attention, and reaction time in chronic and acutely 
infected patients (Hall & Smith, 1993; Corney, Hale & Ball, 
1994). As mentioned previously, HCV, being a virus like 
glandular fever, may also produce a number of deficits in 
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cognition. These deficits may be akin to those found in 
glandular fever patients rather than similar to patients 
infected with any other virus. The reason for this is that 
glandular fever affects the human body in similar ways to 
HCV (e.g. in fever, fatigue and possible liver infection) 
and therefore HCV may result in similar effects upon 
cognitive functioning as glandular fever. 
Human Immunodeficiency Virus (HIV-1)  
HIV attacks and progressively destroys the immune 
system, having a morbid predilection for the brain. Brain 
damage can occur as a direct result of HIV infection 
involving brain cells, or indirectly from tumours or other 
infections, or infectious processes due to a deteriorating 
immune system that is increasingly unable to ward of 
diseases. Asymptomatic HIV type 1 (HIV-1) patients do not 
tend to shown significant cognitive impairment (Mauri, 
Sinforiani, Muratori, Zerboni, 1993; Jonnsen, Saykin, 
Cannon, & Campbell, 1989)). In contrast, symptomatic HIV-1 
is characterised by impaired fine motor control, sustained 
and selective attention, cognitive flexibility, and verbal 
memory (Maj, Sntx, Janssen, & Zaudig, 1994). 
Most of the deleterious effects on cognition and 
behaviour occur when HIV evolves into Acquired 
Imunnodeficiency Syndrome (AIDS). Numerous studies have 
shown that any and every neuropsychological disorder may 
occur in AIDs patients. These include impairments such as 
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memory deficits, mental confusion, mild learning and 
attention deficits, psychomotor slowing, and difficulties 
with visuospatial processing (Selnes, Galais, Bocellar, & 
Miller, 1995; Grant, Atkinson, & Hesselink, 1987; Perdices 
& Cooper, 1989). 	Eventually AIDS resolves into what has 
become known as AIDS Dementia Complex. Navia, Jordan, and 
Price (1986) were the first to describe the progressive 
cognitive deterioration accompanying AIDS, as AIDS Dementia 
Complex. It is characterised by forgetfulness, loss of 
attention, mental slowing, deterioration in executive 
functioning and later, motor dysfunction (Maruff, Currie, 
Malone, & McArthur, 1994). The virus causes these deficits 
by specifically targeting and attacking nervous system 
tissue and for this reason it is termed a 'neurotropic 
virus.' 
The most recent study in this area that clearly shows 
how stage of infection (from HIV to AIDS) influences both 
type and severity of cognitive and behavioural deficits, is 
Perdices (1994) study of neuropsychological (NP) impairment 
resulting from HIV-1 infection. Two hundred and eight 
subjects (Control = 40, Asymptomatic seropositive = 75, 
AIDS-related complex = 61, AIDS = 33) were given a NP 
battery which consisted of 51 measures such as memory, motor 
speed, and reaction time. Based on NP performance after 
principal component analysis with varimax rotation, five 
distinct subgroups were detected. The first was a normal 
performance subgroup, which included the controls. The 
second consisted of subjects with non-specific subclinical 
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decrements in performance. The next two groups exhibited 
impairment consistent with subcortical and frontal cerebral 
pathology (e.g., impoverished verbal memory and visuomotor 
coordination) and finally, the last subgroup experienced 
markedly elevated depression and motor slowing, the latter 
of which may be the result of clinical depression itself. 
No other impairments were apparent in this last group. 
This study clearly shows that distinct empirically 
identifiable patterns of impairment exist in patients with 
HIV-1 infection. However, it would appear that the virus 
does not produce a homogeneous set of deficits, instead 
there are substantial variations in patients' impairment 
between and within particular stages of HIV-1 infection. 
There was also no significant association between impairment 
subtype and stage of HIV infection, although participants 
with normal performance were predominant in the early stages 
of infection. 
Unlike the other viruses previously mentioned, there 
is no dispute concerning whether or not HIV eventually 
results in cognitive deficits, not only because of 
neuropsychological testing and research but because of the 
scientific knowledge that this virus directly attacks 
central nervous system tissue. 
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Possible Biological Mechanisms Underlying Viral 
Cognitive Deficits 
As mentioned, HIV directly invades neural tissue. The 
demonstration of cognitive deficits in patients with AIDS 
is therefore not, a great surprise. But how can cognitive 
impairments in patient groups with infection by viruses 
that do not directly involve the brain be explained? The 
causes for these viral induced psychological deficits have 
not been clearly identified, however, several hypotheses 
have been proposed. These include that the viruses result 
in poor performance via muscle fatigue (Smith, 1993); that 
the symptomatology of each virus leads to different 
performance states (Smith, Tyrrell, Coyle & Willman, 1987) 
and that the infection itself takes a general toll on the 
body's overall reactions (Savory, 1991). None of these 
theories have been conclusively substantiated by the 
research. However, one theory has begun to accumulate 
support over the last decade, and this identifies cytokines 
as the mediators of immunological and behavioural symptoms 
and responses in animals infected with viral illness. 
Symptoms of acute infections resulting from viruses, 
such as loss of appetite, hypersomnia, social withdrawal, 
depressed mood, and impaired concentration and attention, 
collectively referred to as 'sickness behaviour,' have been 
shown to be associated with the action of cytokines such as 
interferons, tumour necrosis factor (TNF) and interleukins 
(IL-1) within the Cental Nervous System (Hart, 1988). 
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Investigation of the neuroimmunological and 
behavioural profiles of sick animals in response to viral 
infection (Hart, 1988; Dantzer, Bluthe, Kent & Kelly, 1992) 
has illustrated that infective disorders result in a 
specific pattern of responses, physiological (increased 
core body temperature, decreased plasma iron and zinc, 
increased slow-wave sleep and weight loss) and behavioural 
(anorexia, decreased psychomotor activity, social 
withdrawal etc). The stereotyped nature of such responses 
and their similarities across species suggest that they are 
mediated by common mechanisms. Research has identified 
that cytokines such as interleukins (IL-1), TNF and 
interferons (alpha and gamma) may be this central 
mechanism. When an animal becomes infected with a virus, 
cytokines begin to be produced in the periphery of the body 
via cells from the immune system (e.g. blood monocytes and 
granular lymphocytes). Once synthesised, they induce a 
series of central nervous system events which are thought 
to produce the physiological and behavioural symptoms or 
'sickness behaviour' often associated with acute viral 
infection. 
A similar process has been shown to occur in humans. 
A range of acute viral illnesses (influenza, upper 
respiratory tract infections and the Epstein-Barr Virus), 
and chronic conditions such as chronic fatigue syndrome and 
hepatitis B (Lloyd, Wakefield, & Hickie, 1993) produce 
viral antigens which in turn result in a cascade of 
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activation of the cellular components of the immune 
response, and that cascade appears to be initiated by the 
release of a variety of cytokines (IL-1, TNF and 
interferons) which cross the blood-brain barrier. The 
range of physiological and behavioural symptoms that then 
occur, such as anorexia, irritability, poor concentration, 
lethargy and decreased motor activity, seem to be 
precipitated by the cytokine release. 
It has been proposed therefore, that cytokines 
initially released in the periphery of the human body in 
response to viral illness may be responsible for the range 
of physiological and behavioural symptoms (such as lethargy 
and poor concentration) observed in individuals with 
infective illnesses (Hart, 1988; Dantzer et al., 1992). 
Hart (1988) proposes that these symptoms or 'sickness 
behaviour' form a survival function, allowing the animal to 
put all its energy reserves and bodily resources into 
killing off the invading pathogen rather than into muscular 
activity from the animal moving about. 
Further support for the hypothesis that cytokines play 
a role in the production of physiological and behavioural 
symptoms during viral infection, comes from interferon 
research. Exogenous interferon has been given as a form of 
treatment to hepatitis C patients and carriers of hepatitis 
B. This treatment has produced symptoms akin to acute 
viral infection, such as fatigue, impaired concentration, 
slowness, disorientation, anxiety and depression, but no 
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organic changes. These symptoms are reversed by stopping 
the interferon treatment (Smedley, Katrak, Sikora, & 
Wheeler, 1983; Renault & Hoofnagel, 1989). As the body's 
immune system naturally produces endogenous interferons 
when it becomes infected with a virus (Smith, Tyrrell, 
Coyle & Willman, 1987), researchers propose that just as 
exogenous interferons produce an exaggerated form of acute 
viral performance symptoms, so the action of endogenous 
interferons produces less severe viral symptoms that 
influence the mental state, causing cognitive deficits such 
as impaired attention and concentration (Smedley, Katrak, 
Sikora, & Wheeler, 1983; McDonald, Mann, & Thomas, 1987). 
Criticisms of Behavioural Virology Research and 
Implications for Future HCV Studies 
The small sample size inherent in many of the viral 
research studies leads to questionable reliability of 
results (Savory, 1992). The majority of infected groups 
used in these studies are small (Smith et al., 1987). As a 
consequence, any variations resulting from individual 
differences could be exaggerated. To some extent this may 
be compensated for by using analyses of covariance, but the 
reliability of the analyses on such small groups is 
questionable. Future research into behavioural virology, 
including the hepatitis viruses, should aim to increase 
participant numbers and improve reliability of results. 
While this is sometimes difficult, due to the small 
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endemicity rate of some viruses, it should not be difficult 
with HCV. In 1994 in Southern Tasmania, 189 people were 
reported as being infected with HCV (Tasmanian Health 
Department, David Coleman, personal communication, 
1995). 
Another difficulty with behavioural virology research 
is that any random sample of participants with a cold or 
influenza for example, is likely to contain multiple 
strains and it is difficult to identify the causative virus 
in a given individual. This makes the studies difficult to 
compare and may account for some variation in results of 
studies that are supposedly examining the same viral 
infection. This is also an issue for any research into 
HCV, as there are six major genetic groups of HCV and a 
number of recognised subtypes that are closely related. As 
mentioned previously, HCV is classified within the 
Flaviviridae family, however, it comprises a heterogenous 
group of RNA viruses. Type 4 infection is the most 
prevalent in Egypt and many parts of the Middle East and 
Africa, whereas genotypes la, lb, 2a, 2b and 3a are the 
most prevalent in patients with chronic HCV from countries 
in Western Europe and the United States. It is therefore 
important when studying HCV patients, to make sure they are 
of a common genotype (Dusheiko, Khakoo, Soni, & Grellier, 
1996). 
Many of the studies on behavioural virology omit 
mention of whether or not they took into account the 
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severity of their participants' illness when considering 
cognitive performance (Smith et al., 1992). Often the 
symptomatology present is recorded but there is no 
reference to any analyses of results that compares the 
impact of symptom severity on task performance. This 
oversight may lead to real deficits being undetected in 
participants who may be more severely incapacitated with a 
virus because they are included with a majority of 
participants who are relatively well functioning. In 
principle, at least, this problem can be overcome in 
hepatitis research by separating the symptomatic from the 
asymptomatic patients and separately analysing and 
comparing their data. The importance of determining 
symptom severity and separating symptomatic from 
asymptomatic patients is apparent in HIV research, which 
has shown asymptomatic patients to be relatively 
cognitively unimpaired (Mouri, Sinforiani, Muratori, & 
Zerboni, 1993; Jonnson, Saykin, Cannon, & Campbell, 1989), 
but symptomatic patients to show significant cognitive 
deficits (Maj et al., 1994). 
In addition, it is unclear in many of the viral 
studies whether or not the control and experimental groups 
were matched for gender and age (Smith, 1992), and whether 
there were equal numbers of each sex in the groups. 
Research suggests that age (Smith & Brewer, 1985) and 
gender (Gulian & Thomas, 1986) may be important in 
influencing performance under certain conditions and should 
therefore be controlled. In Smith et al.'s (1987) study of 
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Influenza B, any differences in performance on some tests 
could have been influenced by the imbalance of gender in 
the control and experimental groups. For example, the 
experimental group consisted of three infected females, and 
the control group consisted of two females and five males. 
Future viral research should ensure that experimental and 
control groups have equal proportions of males and females, 
and that they are matched for age. 
It is also important when studying the behavioural 
effects of viruses to screen participants for depression. 
Often in response to diagnosis or in response to ongoing 
illness, a reactive form of depression can occur. 
Depression has been found to interfere with cognitive 
functioning. For example, it has been found to cause 
concentration and attention problems in cognitive tasks 
(Mialet, Pope, & Yurgelun-Todd, 1996). It is therefore 
important either to screen out potential HCV participants 
who have accompanying depression or to statistically 
control for this confounding variable, as the effects of 
this disorder may obscure the effects of HCV. 
Many viral infections result in the patient being 
prescribed treatment medication, and yet some behavioural 
virology researchers fail to mention whether they screened 
subjects for medication use (Perdices, 1994). The effects 
of medication may make it difficult to determine whether 
any deficits in performance are due to the virus or the 
treatment. Future viral research, such as HCV studies, 
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should take this into account and/or exclude participants 
on medication. Alpha Interferon (Al), is the medication 
used to treat a minority of chronic HCV patients. It tends 
to produce long-term remissions in only 10-25% of patients. 
Generally, 4-8 hours after initial treatment, an influenza-
like condition of fever, chills, anorexia, nausea, sleep 
disturbance, and fatigue occurs, but this lessens with 
subsequent injections. Al has been reported to produce 
stable cognitive deficits such as mental torpor, short term 
memory difficulty, and reduction in concentration (Renault 
& Hoofnagle, 1989, in Zuckerman & Thomas, 1993). Treatment 
is therefore a potential confounding variable, hampering 
determination of whether any deficits identified would be 
due to HCV itself. However, as Al is only given to a small 
percentage of patients with definite liver damage and is an 
expensive treatment, sufficient unmedicated chronic HCV 
patients should still be available to research, thus 
avoiding any possible confounding effects of treatment. 
The issue of fatigue is also important in behavioural 
virology research, particularly in relation to HCV, where 
fatigue is often a reported symptom. It is often difficult 
to determine whether any deficits identified in research 
are due to cognitive slowing or physical fatigue, as a 
result of the virus. Counterbalancing the order of test 
presentation can overcome this problem, but few viral 
studies have reported whether they follow this procedure. 
Future research would benefit from both counterbalancing 
tasks as well as attaining a pure measure of motor fatigue 
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by administering a specific task at the beginning and end 
of each test session, such as simple reaction time, and 
determining if there was any motor slowing throughout the 
session. 
Conclusions 
It is a commonly held belief that when suffering from 
a viral infection, individuals perform less efficiently. 
Gradually, research has been gathered that tends to 
generally support such claims and illustrate that there are 
clear deficits in memory, attention, reaction time, motor 
coordination, perception, and other skills during the 
course of infection by particular viruses. The majority of 
viral illnesses studied have been shown to produce some 
form of deficit, and therefore it is likely that hepatitis 
C being itself a viral illness, would also produce one or 
more deficits in cognitive performance. In addition, 
glandular fever patients during both the chronic and acute 
stage of the illness have exhibited deficits in memory, 
attention, and reaction time. As this virus shares some 
common symptoms with HCV, it is also quite possible that 
any deficits identified will be similar to those found in 
glandular fever patients. 
A crucial aspect of the care of patients with HCV is 
general advice, knowledge, and counselling. HCV has 
received considerable media attention in recent years and 
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as a result, many people may harbour misconceptions about 
the nature of the disease. One of the most important 
issues for patients diagnosed with HCV therefore is 
appropriate education and support: "...they require 
accurate information and emotional support to help them 
come to terms with their diagnosis." (Wilson, 1993, p. 4) 
All clients should be provided with basic information and 
counselling, including knowledge about the natural course 
of the illness, duration, how HCV is transmitted, behaviour 
change which can prevent the spread of HCV, and what HCV is 
and its possible effects, both physiological and cognitive. 
The latter can only be determined through extensive 
research into the virus. 
Investigation into HCV will help determine for example 
whether or not patients are likely to suffer from any ill 
effects upon memory, attention, reaction time, and so 
forth, which in turn have implications for their ability to 
safely perform tasks utilising those skills, such as 
driving, studying, and occupational efficiency. In 
particular, reaction time, attention, and tracking skills 
which have been shown to be affected by viral illnesses 
such as glandular fever, are needed to operate and keep 
vehicles on the road, handle occupational machinery and 
monitor sources of information such as road signs and 
pedestrians. 
Any deficits in mental performance and behaviour 
discovered as a result of HCV investigations also have the 
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potential for being a valuable contributor to any 
prevention or harm reduction education campaigns. Just as 
informing people of possible physiological effects of the 
disease (liver infection and cancer) often make people more 
careful to avoid engaging in 'at risk' behaviours for 
contracting the disease (ie. not sharing needles, covering 
cuts and wounds and practicing safer sex), likewise, 
informing the public of possible cognitive deficits may 
have a similar impact. 
The merit of research into viral illness is clearly 
valuable in terms of community education and prevention, 
for learning more about the virus, its effects and 
Implications for those infected. However, HCV, more 
prevalent than HIV or AIDS at the moment in Australia has 
been overlooked in terms of its effect on behaviour and 
cognition. Patients are in need of knowledge concerning 
their illness, its effects and prognoses, yet before this 
can be provided there needs to be some extensive changes in 
experimental design. Studies into behavioural virology 
have been subject to numerous methodological weaknesses in 
the past. Recommendations for design improvement include 
having controls matched for sex and age, and clearly 
delineating experimental groups in terms of symptom 
severity and stage of illness (chronic versus acute) so 
that any deficits within the infected group are not 
overlooked. Participants must also be screened for 
depression, medication, and coexisting illnesses, all of 
which could interfere with findings. Finally, there needs 
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to be an increase in participant numbers in order to obtain 
more reliable results and increased statistical pourer. 
36 
References 
Australian Gastroenterology Institute (AGI). (1991). 
Hepatitis C: An information leaflet for patients and 
interested members of the general public. Sydney: 
AGI. 
Barrow, G. I., Coyle, K. B., Higgins, P. G., Al-Nakib, W., 
Smith, A. P., Wenham, R. B. M., & Tyrrell, D. A. J. 
(1990). The effect of intranasal nedocromil sodium on 
viral upper respiratory tract infections in human 
volunteers. Clinical Experimental Allergy, 20, 45-51. 
Baur, P., Daniel, V., Pomer, S.,Scheurlen, H., Opelz, G., & 
Roelcke, D. (1991). Hepatitis C virus (HCV) 
antibodies in patients after kidney transplantation. 
Annals of Hematology, 62, 68-73. 
Bell, J., Batey, R. G., Farrell, G. C., Crewe, E. B., 
Cunningham, A. L., & Byth, K. (1990). Hepatitis C 
virus in intravenous drug users. Medical Journal of 
Australia, 153(5), 274-276. 
Bowden, D. S., Moaven, L. D., & Locarnini, S. A. (1996). 
New hepatitis viruses: are there enough letters in 
the alphabet? Medical Journal of Australia, 164, 
87-89. 
37 
Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., 
Bradley, D. W., & Houghton, M. (1989). Isolation of a 
DNA clone derived from a blood-borne non-A, non-B 
hepatitis genome. Science, 244, 359-362. 
Coltheart, M. (1981). The MRC psycholinguistic database. 
Quarterly journal of Experimental Psychology, 33A, 
497-505. 
Cope, H., Pernet, A., Kendall, B., & David, A. Cognitive 
functioning and magnetic resonance imaging in chronic 
fatigue. British journal of Psychiatry, 167, 86-94. 
Corney, T., Hale, R., & Ball, P. (1994). Two experiments 
on mental functioning under common health-related 
conditions: Glandular Fever and the Premenstrual 
phase. Treatment Issues and Long-term Outcomes: 
Proceedings of the 18th Annual Brain Impairment 
Conference. Queensland: Australian Academic Press. 
Dantzer, R., Bluthe, R. M., Kent, S., & Kelly, K. W. 
(1992). Behavioural effects of cytokines. In: 
Rothwell, N. J., Dantzer, R., eds. Interleukin-1 in 
the brain. Oxford: Pergamon Press, 1992. 
Daugherty, S. A., Henry, B. E., Peterson, D. L., Swarts, R. 
L., Bastien, S., & Thomas, R. S. (1991). Chronic 
fatigue syndrome in northern Navada. Review of 
Infectious Diseases, 13, 39-44. Abstract. 
38 
De La Harpe, M. (1995). Study confirms concern over Hep C. 
Campus Review, 5, Oct-Nov, 18. 
DeLuca, J., Johnson, S. K., Beldowicz, D., & Natelson, B. 
H. (1995). Journal of Neurology, Neurosurgery and 
Psychiatry, 58, 38-43. 
Deluca, J., Johnson, S. K., & Natelson, B. H. (1993). 
Information processing in chronic fatigue sydrome, 
multiple sclerosis and depression. Archives of 
Neurology, 50, 301-304. 
Dusheiko, G. M., Khakoo, S., Soni, P., & Grellier, L. 
(1996). A rational approach to the management of 
hepatitis C infection. British Medical Journal, 312, 
357-364. 
Dusheiko, G. M., Smith, M., & Scheuer, P. J. (1990). 
Hepatitis C virus transmitted by human bite. Lancet, 
336, 503-504. 
Eyster, M. E., Alter, H. J., Aledort, L. M., Quan, S., 
Hatzakis, A., & Goedert, J. J. (1991). Heterosexual 
co-transmission of hepatitis C virus (HCV) and human 
immunodeficiency virus (HIV). Annals of Internal 
Medicine, 115(10), 764-768. 
39 
Fairley, C. K., Leslie, D. E., Nicholson, S., & Gust, I. D. 
(1990). Epidemiology and hepatitis C virus in 
Victoria. Medical Journal of Australia, 153(5), 271- 
273. 
Golub, S. (1976). The effect of anxiety and depression on 
cognitive function. Journal of Personality and Social 
Psychology, 34, 99-104. 
Grant, I., Atkinson, J., & Hesselink, J.R. (1987). 
Evidence for early central nervous system involvement 
in the acquired immunodeficiency virus (AIDS) and 
other human immunodeficiency virus (HIV) infections: 
Studies with neuropsychologic testing and magnetic 
resonance imaging. Annals of Internal Medicine, 107, 
828-836. 
Gulian, E., & Thomas, J. R. (1986). The effects of noise, 
cognitive set and gender on mental arithmetic 
performance. British Journal of Psychology, 77, 503- 
511. 
Hall, S. R., & Smith, A. P. (1993). Behavioural effects of 
infectious mononucleosis. Unpublished manuscript. 
Health Psychology Research Unit: University of Wales. 
Hart, B. (1988). Biological basis of the behavior of sick 
animals. Neuroscience and Biobehavioral Reviews, 12, 
123-137. 
40 
Jonssen, R. S., Saykin, A. J., Cannon, L., & Campbell, J. 
(1989). Neurological and neuropsychological 
manifestations of HIV-1 infection: Association with 
AIDS-related complex but not asymptomatic HIV-1. 
Annals of Neurology, 26(5), 592-600. 
Lloyd, A. R., Hickie, I., & Peterson, P. K. (1997). 
Chronic Fatigue Syndrome, in Richman, D., Whitley, R. 
J., & Hayden, F. G. (eds), 1997, Clinical Virology. 
New York: Churchill Livingstone, ppL343-355. 
Lloyd, A. R., Wakefield, D, & Hickie, I. (1993). Immunity 
and the pathophysiology of chronic fatigue syndrome. 
[Abstract]. Chronic Fatigue, pp.176-192. CIBA 
Foundation. London. 
Maj, M., Sntx, P., Janssen, R., & Zaudig, M. (1994). 
WHO neuropsychiatric AIDS study, cross-sectional phase 
II: Neuropsychological and neurological findings. 
Archives of General Psychiatry, 51(10), 51-61. 
Maruff, P., Currie, J., Malone, V., & McArthur-Jackson, C. 
(1994). Neurological characterisation of the 
AIDS dementia complex and rationalisation of a test 
battery. Archives of Neurology, 51(7), 689-695. 
Mauri, M., Sinforiani, E., Muratori, S., & Zerboni, R. 
(1993). Three year neuropsychological follow-up in 
41 
a selected group of HIV-infected homosexual and 
bisexual men. AIDS, 7(2), 241-245. 
McDonald, E. M., Mann, A. H., & Thomas, H. C. (1987). 
Interferons as mediators of psychiatric morbidity. 
The Lancet, 2, 1175-1177. 
Mialet, J. P., Pope, H. G., & Yurgelun-Todd, D. (1996). 
Impaired attention in depressive states: a non-
specific deficit? Psychological Medicine, 26, 1009- 
1020. 
Moss-Morris, R., Petrie, K. J., Large, R. G., & Kydd, R. R. 
(1996). Neuropsychological deficits in chronic 
fatigue syndrome: artifact or reality? journal of 
Neurology, Neurosurgery, and Psychiatry, 60, 474-477. 
Navia, B., Jordan, B. D., & Price, R. W. (1986). The AIDS 
dementia complex: I. Clinical features. Annals of 
Neurology, 19, 517-524. 
New South Wales Department of Health. (1993). Hepatitis C: 
Ten Questions and Answers. Sydney: CEIDA. 
Perdices, M. (1994). Profiles of selective 
neuropsychological impairment in HIV-1 infection. 
Treatment Issues and Long-term Outcomes: Proceedings 
of the 18th Annual Brain Impairment Conference. 
Queensland: Australian Academic Press. 
42 
Perdices, M. & Cooper, D. A. (1990). Neuropsycholgical 
investigation of patients with AIDS and ARC. JAIDS, 
3, 555-564. 
Prasher, D., Smith, A., & Findley, L. (1990). Sensory and 
cognitive event related potentials in myalgic 
encephalomyelitis. Journal of Neurology, Neurosurgery 
and Psychiatry, 42, 253-257. 
Savory, M. A. (1991). Selective effects of colds and 
influenza on human performance efficiency: A critical 
appraisal. Neuropsychobiology, 25, 153-160. 
Scheffers, M. K., Johnson, R., Jr., Grafman, J., Dale, J. 
K., & Straus, S. E. (1992). Attention and short-term 
memory in chronic fatigue syndrome patients. 
Neurology, 42, 1667-1675. 
Selnes, 0. A., Galai, N., Bocellar, H., & Miller, E. N. 
(1995). Cognitive performance after progression to 
AIDS: A longitudinal study from the Multicenter 
AIDS cohort study. Neurology, 45(2), 267-275. 
Smedley, H., Katrak, M., Sikora, K., & Wheeler, T. (1983). 
Neurological effects of recombinant human interferon. 
British Medical Journal, 286, 262-264. 
43 
Smith, A. P. (1990). Respiratory virus infection and 
performance. Philosophical Transactions of the Royal 
Society of London. B327, 519-29. 
Smith, A. P. (1992a). Chronic fatigue syndrome and 
performance. In A. P. Smith & D. M. Jones (Eds.), 
Handbook of human performance: Vol 2. London: 
Academic Press. 
Smith, A. P. (1992b). Effects of influenza and the common 
cold on the Stroop Colour-Word Test. Perceptual and 
Motor Skills, 74, 668-670. 
Smith, A. (1993). Behavioural abnormalities associated 
with the chronic fatigue syndrome. Unpublished 
manuscript. 
Smith, A. P., Behan, P. 0., Bell, W., Millar, K., & 
Bakheit, M. (1993). Behavioural problems associated 
with the chronic fatigue syndrome. British Journal of 
Psychology, 84, 411-423. 
Smith, A. P., & Jones, D. M. (Eds.). (1992). Handbook of 
human performance: Vol 2. London: Academic Press. 
Smith, A. P., Thomas, M., Brockman, P., Kent, J., & 
Nicholson, K. G. (1993). Effect of influenza B virus 
on human performance. British Medicine Journal, 306, 
760-761. 
44 
Smith, A. P., Tyrrell, D. A. J., Al-Nakib, W., Coyle, K. 
B., Donovan, C. B., & Higgins, P. G. (1988). The 
effects of experimentally-induced respiratory virus 
infections on performance. Psychological Medicine, 
18, 65-71. 
Smith, A. P., Tyrrell, D. A. J., Al-Nakib, Barrow, G. I., 
Higgins, P. J., Leekam, S., & Trickett, S. (1989). 
Effects and after-effects of the common cold and 
influenza on human performance. Neuropsychobiology, 
21, 90-93. 
Smith, A. P., Tyrrell, D. A. J., Barrow, G. I., Coyle, K. 
B., Higgins, P. G., Trickett, S., & Willman, J. S. 
(1990). Effects of experimentally induced colds on 
aspects of memory. Perceptual and Motor Skills, 71, 
1207-1215. 
Smith, A. P., Tyrrell, D. A. J., Barrow, G. I., Higgins, P. 
G., Bull, S., Trickett, S., & Wilkins, A. J. (1992). 
The common cold, pattern sensitivity, and contrast 
sensitivity. Psychological Medicine, 22, 487-494. 
Smith, A. P., Tyrrell, D. A. J., Coyle, K., & Willman, J. 
S. (1987). Selective effects of minor illnesses on 
human performance. British Journal of Psychology, 
78, 183-188. 
45 
Smith, G. A., & Brewer, N. (1985). Age and individual 
differences in correct and error reaction times. 
British Journal of Psychology, 76, 199-203. 
Thaler, M. M., Park, C. K., & Landers, D. V. (1991). 
Vertical transmission of hepatitis C virus. Lancet, 
338, 17-18. 
Tibbs, C. J. (1995). Methods of transmission of hepatitis 
C. Journal of Viral Hepatitis, 2, 113-119. 
Wilson, C. (1993). Hepatitis C - Essential information. 
The Newsletter of the Alcohol and other Drugs Council 
of Australia, 7(2), 1-4. 
Zuckerman, A. J., & Thomas, H. C. (Eds) (1993). Viral 
Hepatitis : Scientific Basis and Clinical Management. 
New York: Churchill Livingstone. 
46 
Behauioural Virology Research: The 
Cognitiue and Perceptual-Motor 
Performance of Chronic Primarily 
Asymptomatic Hepatitis C Patients 
Rowena Hale (B.R., Hon.) 
Journal Article 
A report submitted as a partial 
requirement for the degree of Masters 
of Clinical Psychology in the Department 
of Psychology, Uniuersity of Tasmania, 
1996. 
Abstract 
This study examined the effects of chronic primarily 
asymptomatic hepatitis C (HCV) upon cognition and 
perceptual-motor skills. A battery of six performance 
tasks measuring concentration, reaction time, hand-eye 
coordination and attention were given to 12 HCV patients 
and 12 controls matched for age, sex, and intravenous drug 
history (if applicable). The hypothesis that HCV 
participants would exhibit performance deficits as have the 
majority of viruses currently investigated and that like 
glandular fever patients, with whom they share some 
commonalities, these deficits would be slowed reaction 
time, impaired attention, and memory was generally 
supported. A series of ANOVAs revealed that HCV 
participants had significantly slower reaction times that 
could not be attributed to fatigue alone, and impaired 
perceptual-motor skills as measured by a Pursuit task. 
Both these tasks also tap into sustained attention. 
However, no decreases in memory performance were detected. 
Implications of the findings for safety, patient 
counselling, education, and future investigations were 
discussed. 
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Viral hepatitis can be simply described as ". . 
inflammation of the liver. . . ," caused by a ". . . tiny 
microscopic infectious germ." (Australian Gastroenterology 
Institute, 1991, p.2). Of all the hepatitis viruses, viral 
hepatitis C (HCV), is the most common disease and a major 
global public health problem. HCV is a novel agent, closely 
related to both animal pestiviruses (e.g., bovine viral 
diarrhoea and hog cholera) and to the human flaviviruses 
(e.g., yellow fever and dengue fever). It is classified in 
the Flaviviridae family, but as a separate genus. HCV is 
now the most common hepatitis virus, affecting about 0.4% 
(1 in 250) of the Australian community (Australian 
Gastroenterology Institute, 1991). HCV can cause acute 
(short-lived) disease, which may resolve completely, but in 
50% of patients leads to chronic hepatitis (greater than 6 
months) (Zuckerman & Thomas, 1993). 
It is commonly believed that people perform less 
efficiently when suffering from viral illnesses such as 
HCV. However, in contrast to the well studied and 
documented physiological effects of viruses, little 
research has been conducted to rigorously examine any 
possible effects of viruses on cognition or mental 
functioning (Savory, 1992). In addition, the 
investigations that have been conducted have focussed on 
only a select number of viral infections. 
The common cold, Human Immunodeficiency Virus (HIV), 
influenza, and Infectious Mononucleosis (IM or glandular 
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fever) viruses have been studied in terms of their effects 
on aspects of human performance, such as memory, attention, 
and speed of reaction. So far however, the hepatitis 
viruses, including HCV have avoided the scrutiny of the 
investigator's eye. One possible reason why HCV has been 
neglected in behavioural virology research revolves around 
its association with intravenous (IV) drug use. A large 
percentage of individuals with HCV are IV users who 
contracted the virus through shared contaminated needles 
(Bell, Batey, Farrel, Crewe, Cunningham, & Byth, 1990). IV 
drug use in participants has been viewed as a confounding 
factor that would be difficult, but not impossible, to 
control for in experimental research. 
Currently research has found that the majority of the 
viruses studied produce cognitive deficits. Participants 
infected with common cold viruses, mainly Respiratory 
Syncytial Virus, Coronavirus, and Rhinovirus have been 
found to be more sensitive to a visually distracting 
pattern, report more illusions, and show impaired attention 
compared to controls (Smith, Tyrrell, Barrow, Higgins, 
Bull, Trickett, & Wilkins, 1992; and Smith 1992). Research 
into participants who were challenged with and then 
developed infection from Coronavirus or Rhinoviruses RV2, 
RV9, or RV14, found that the immediate recognition of 
important information from a 15 minute story was impaired, 
suggesting they were less able to follow the theme of a 
story. Influenza B has also been found to produce 
significantly longer reaction times (Smith, Thomas, 
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Brockman, Kent, & Nicholson, 1993; Smith, Tyrrell, Al-
Nakib, Barrow, Higgins, Leekam, & Trickett, 1987), with 
slower repeated numbers detection and reduced accuracy at 
categoric search (Smith et al., 1993). 
Likewise, symptomatic HIV-1, a virus that directly 
attacks the immune system and the brain, has produced its 
own pattern of deficits, these range from impoverished 
verbal memory and visuomotor coordination to motor slowing 
(Maj, Sntx, Janssen, & Zaudig, 1994). When HIV resolves 
into AIDS these neuropsychological deficits increase to 
encompass impairments in memory, learning, attention, 
visuospatial processing, and psychomotor performance 
(Selnes, Galais, Bocellar, & Miller, 1995). 
Chronic Fatigue Syndrome can be included in the 
behavioural virology research area because it has possible 
viral origins, such as Retro or Enteroviruses (Lloyd, 
Hickie, & Peterson, 1995). Its effects on cognition have 
been reported to be slowed psychomotor responses, and 
impaired semantic processing and logical reasoning (Smith, 
Behan, Bell, Millar, & Bakheit, 1993), deficits in 
attention, motor skills, memory, and problem solving 
(Daugherty, Henry, Peterson, Swarts, Bastein, & Thomas, 
1991; Smith 1992). As CFS patients are usually seen many 
months, if not years, after the original illness, it is 
problematic however to attribute the fatigue related 
symptoms to a preceding viral illness and to determine what 
if any virus is responsible for any cognitive impairments. 
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Each of these viral illnesses has resulted in a range 
of performance deficits which have provided empirical 
support to self reported decreases in performance 
efficiency during viral illnesses. It is probable 
therefore that HCV would also result in measurable 
performance decrements. Interestingly HCV shares some 
common symptomatology with glandular fever, mainly fatigue, 
fever, and possible liver infection. As acute IM 
participants have shown significantly slower reaction 
times, difficulties in sustaining attention (Hall & Smith, 
1993; Corney, Hale, & Ball, 1994), and chronic IM patients 
have exhibited memory deficits and lowered accuracy in a 
logical reasoning task when compared to controls (Hall & 
Smith, 1993), it is plausible that HCV may result in a 
similar profile of cognitive deficits as those produced by 
glandular fever. 
The causes for these viral psychological deficits have 
not been clearly identified within the literature, however, 
several psychomotor hypotheses have been proposed. These 
include that the viruses lead to muscle fatigue resulting 
in poor performance (Smith, 1993); that the particular 
symptomatology of each virus leads to different performance 
states (Smith et al., 1987); that cytokines such as alpha 
interferon and interleukins released by the immune system 
affect performance (Hart, 1988: Dantzer, Bluthe, Kent, & 
Kelly, 1992); and that the infection itself takes a toll on 
the body's overall reaction (Savory, 1991). To date, no 
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theory has been unequivocally substantiated by the research 
in question. 
The difficulty when embarking into research on the 
cognitive effects of HCV, is to avoid the numerous 
methodological flaws inherent in behavioural virology 
research. Savory (1992) has criticised small sample sizes 
(as low as 3) which have led to questionable reliability of 
results (Smith et al., 1987) and experimental and control 
groups often not matched for gender and age (Smith et al., 
1987). Some researchers fail to mention whether they 
screened participants for medication which can be 
prescribed for viral infections (Perdices, 1994). Length 
of illness (acute or chronic) and symptom severity 
(symptomatic or asymptomatic) has also tended to be 
overlooked and researchers have failed to delineate groups 
based upon these criteria (Smith et al., 1987; Smith et 
al., 1989). All these extraneous factors may have resulted 
in real deficits going undetected. Finally, fatigue has 
not been sufficiently taken into account. It is possible 
that rather than any specific cognitive deficits, patients 
with a viral illness may be suffering general fatigue which 
in turn results in poor performance. 
There is clearly a case for a study to establish 
whether, like glandular fever, HCV impairs cognitive and 
perceptual-motor functioning, and if so, what the profile 
of impairments is. In the present study, the performance 
of two groups of participants, 12 HCV patients and 12 
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controls was compared on a single battery of cognitive and 
perceptual-motor tasks. All HCV participants were in the 
chronic stage of the illness (an acute group could not be 
obtained) and were primarily asymptomatic, but reporting 
mild symptomatology in common with glandular fever 
patients, such as fatigue. HCV patients and controls were 
matched for age, sex, and drug history. To eliminate any 
confounding variables, all participants were screened for 
depression, medication, and other viral infections. The 
design permitted comparisons between groups, and consisted 
of a battery of performance tasks including tests of 
memory, reaction time, concentration, attention, and 
perceptual-motor skills. It was predicted that HCV 
patients would exhibit a profile of cognitive performance 
deficits as have sufferers from the majority of viruses 
studied and that like glandular fever, with which HCV 
shares some symptomatology, these deficits would consist of 
significantly slower reaction times, poor attention, and 
memory deficits in patients when compared to controls. 
Method 
Participants  
Participants were 24 volunteers, 4 males and 8 
females, infected with chronic, primarily asymptomatic HCV, 
and 4 male and 8 female uninfected controls. Twenty other 
volunteers were excluded from the study due to continued IV 
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drug use and other concurrent viral illnesses such as 
hepatitis B. 
Participants were recruited from the southern region 
of Tasmania via advertising and information provided by 
General Practitioners and through cooperation with liver 
specialists. They were matched for sex, age, and level of 
education. Ages ranged from 22 to 84, with no significant 
difference in age between controls and HCV participants, 
1(1, 22) = .00, 2 = .97. In addition, there was no 
significant difference between the mean number of years of 
education for controls (12.25) and the mean number of years 
of education for the HCV group (12.17), F(1, 22) = .007, 2. 
= .93. 
The four HCV participants who were past intravenous 
drug users were each matched with a control of similar drug 
history (drug used, time period of use, years since last 
injection) who did not have HCV (see Table 1). Based upon 
screening criteria prior to experimental testing, 
participants were not believed to be using medication or 
drugs, were not clinically depressed (all scored '0' on the 
Beck Depression Inventory, BDI, 1978), and had no other 
concurrent viral infections, disorders or illnesses. 
Participants self-reported an absence of visual or auditory 
impairment. 
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Table 1 
IV Drug History of Control and HCV Participants  
HCV participants Control participants 
Age Past Drug 	Yrs. Yrs. Age Past Drug Yrs. Yrs. 
TV used 	of since IV used of since 
user use used user use used 
82 No - 	- - 83 No - - - 
64 No - 	- - 64 No - - - 
36 No - 	- - 38 No - - - 
38 No - 	- - 38 No - - - 
60 No - 	- - 58 No - - - 
38 No - 	- - 40 No - - 
50 No - 	- - 49 No - - - 
22 No - 	- - 23 No - - - 
22 Yes Speed 1 4 23 Yes Speed 1 4 
34 Yes Speed 2 11 32 Yes Speed 1 10 
Heroin Heroin 
34 Yes Speed 1 5 32 Yes Speed 5 7 
25 Yes Speed 8 2 28 Yes Speed 8 3 
Heroin Heroin 
Note. Yrs. = Years. 
Apparatus  
Participants were screened for clinical depression via 
the Beck Depression Inventory (BDI, 1978). The inventory 
consists of 21 groups of statements such as: 
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0 I do not feel sad. 
1 I feel sad. 
2 I am sad all the time and I can't snap out of it. 
3 I am so sad or unhappy that I can't stand it. 
Participants select the one statement in each group that 
describes how they have been feeling for the 'past week, 
including today.' The BDI produces subscale scores for 
cognitive-affective and somatic-performance aspects of 
depression, as well as the more widely used total depression 
score. All participants in both groups failed to score on 
the BDI, indicating no self-reported depression. 
HCV participants were medically classified as 
primarily 'asymptomatic' by their general practitioners, 
but before participation were asked to record on a form if 
they experienced any psychological or physiological 
symptoms associated with their chronic HCV. All reported 
only increased fatigue. 
All performance tasks were presented on an IBM 
Compatible 486 computer with a colour monitor, keyboard and 
mouse. Subjects were allowed to observe the display from 
the distance they found most comfortable. 
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Tasks  
The performance tasks were subdivided into three main 
groups, although some of these tasks could be included in 
more than one classification: 
Psychomotor 	Pursuit Rotor, Variable Foreperiod 
Simple Reaction Time and Choice 
Reaction Time 
Memory 	Free Recall and Delayed Recognition 
Attention/ 	Stroop Colour-Word Task 
Concentration 
Details of these tests follow: 
Variable fore-period simple reaction time. Each trial 
began with a one-second pause during which the screen was 
clear. A tone then sounded and at a random interval 1-5 
seconds later, a circle of 10mm radius was presented on the 
middle of the monitor and the participant had to press a key 
as quickly as possible. The next trial then began. If the 
participant failed to respond to the stimulus within a 1000ms 
'timeout' period, the next trial began regardless. The task 
consisted of 30 trials and mean reaction time was recorded. 
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Pursuit rotor task. At a speed of 8rpm, a circular 
target of 10mm radius moved clockwise along a regular path of 
60mm radius on the monitor. Participants controlled a white 
cross-shaped cursor with the computer mouse, attempting to 
keep the cursor in contact with the target circle. The task 
lasted one minute and the percentage of time on target was 
recorded. 
Choice reaction-time. On each trial of this task, the 
participant had to choose and execute the correct response to 
one out of a number of possible stimuli. There were nine 
squares forming a three by three matrix on the screen, any 
one of which could light up red on each trial. For each 
square there was a corresponding response key on the numeric 
keypad. When a square lighted up red the participant had to 
press the corresponding response key as quickly as possible. 
However, before a square could - turn red, the participant had 
to hold down a 'home key' (number '5') to ensure their hand 
was always in the same position at the beginning of the 
trial. The stimulus was presented 500ms after the home key 
was first pressed. The stimulus remained illuminated until 
the participant pressed a response key. The number of trials 
was 56 and 'timeout' for responses occurred at 1000ms. 
Overall reaction time was measured for how quickly the 
participant could respond, as well as thinking time (time 
taken before the finger was lifted from the home key) and 
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movement time (time taken between lifting the finger from the 
home key and pressing the response key). 
Free recall. Participants were shown a list of 20 words 
(Appendix A) presented at a rate of one every 2 seconds. At 
the end of the list, participants were given 30 seconds to 
write down (in any order) as many words as they could 
remember. The word list was obtained from the MRC 
Psycholinguistic Database (Coltheart, 1981). They consisted 
of one-syllable five-letter nouns which were not capitalised, 
and possessed familiarity, written frequency, concreteness, 
imagery, and meaningfulness ratings substantially greater 
than 0. The number of words correctly recalled was recorded. 
Delayed recognition memory. At the completion of the 
test session, participants were shown 40 randomly ordered 
words in succession, at the rate of one every 2 seconds. 
These included the 20 words from the Free Recall task, plus 
20 distractors (Appendix A) also taken from the MRC 
Psycholinguistic Database (Coltheart, 1981). Like the Free 
Recall words, distractors were five-letter nouns, of one 
syllable, and possessed similar ratings of familiarity, 
concreteness, imagery, written frequency, and meaningfulness. 
The task was to indicate whether or not each word was a 
member of the previous Free Recall list by pressing, as 
quickly as possible, the 'S' for same or "D' for different 
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button on the response board. The percentage of words 
correctly identified was recorded. 
Stroop colour-word task. In this task there were two 
conditions, in each of which participants were presented with 
a colour name, centred on the computer screen and displayed 
in one of ten colours. On the screen, underneath the colour 
name was a row of four coloured boxes, which were represented 
by four keys on the keyboard (keys '1,"2,"3,' and '4'). 
In condition 1, participants had to respond only to the word, 
ignoring the colour of the ink. For example, if the word was 
'green', and box number 2 was green, then the subject would 
press button '2' on the keyboard as quickly as possible. In 
the second condition, participants responded only to the ink 
colour, ignoring the word. For example, if the word 
'yellow,' was displayed in brown ink, and box number 4 was 
brown, then the participant would press button '4' on the 
keyboard as quickly as possible. There were 100 trials 
presented in four blocks in each condition, with a 50ms delay 
between trials. The ten colours used were: red, green, white, 
black, blue, cyan, magenta, yellow, brown and gray. Prior to 
commencement of this task it was ascertained that all 
participants could distinguish these colours. Reaction times 
and number of correct responses were recorded for each 
condition. 
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Procedure 
Participants completed each performance task once, with 
the exception of simple reaction time, which was tested both 
at the outset and at the end of the single experimental 
session. 
At the beginning of the test session, participants were 
initially given a consent form to complete. A BDI was also 
completed, as was an information sheet (see Appendix B) which 
looked at issues such as intravenous drug use and any 
symptoms HCV participants experienced. In addition, 
participants signed forms giving the researcher permission to 
obtain from their General Practitioners, their HCV status, 
list of medications used, and any other viruses contracted. 
Participants were then informed that they could take a short 
break between tasks if they so desired. Test instructions 
were presented on the computer screen and the tasks were 
counterbalanced for each subject, with the exception of 
three. Simple reaction time was always given as the first 
and last test, as a measure of fatigue, and free recall was 
always the second test and delayed recognition the second 
last. The session required approximately 1 hour. 
Results 
A series of between groups analyses of variance (ANOVAs) 
(Appendix C) were performed on the raw data (Appendix D) from 
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each of the six performance tasks. The independent variable 
included in all the analyses was group (HCV vs Control). 
Significance levels were p<.05 for ANOVAs. A repeated 
measures analysis of variance was also carried out on HCV and 
control participants' simple reaction time scores at the 
beginning and end of the test session. 
Free Recall  
The between groups ANOVA carried out on the number of 
words correctly recalled was not statistically significant, 
F(1, 22) = .27, p = .61. 
Delayed Recognition Memory 
The number of correct responses and the average reaction 
time of correct responses were analysed in two separate 
ANOVAs. The main effect of group failed to reach 
significance for the former (F(1, 22) = 2.15, 2 = .16] and 
the latter data [f(1, 22) = .31, 2 = .58]. 
Pursuit Rotor Task 
The mean percentage of contact for each group was 
analysed. The main effect of grout) reached significance F(1, 
22) = 4.61, p = .04, with Table 2 illustrating that HCV 
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participants possessed a lower mean percentage of time on 
target than controls. 
Table 2 
Mean Percentage of Contact on Target in the Pursuit Rotor 
Task for HCV and Control Participants  
Variable Label SD 
Entire Population 49.50 18.51 24 
Group HCV 41.97 17.53 12 
Group Control 57.04 16.87 12 
Variable Fore-period Simple Reaction Time 
There was no 'timeout' data, as both groups responded to 
the stimulus within the 500ms period given before the next 
trial began. 
Each group had two reaction time measures, one at the 
beginning and one at the end of the test session. A 
repeated measures analysis of variance was carried out on HCV 
and control participants' simple reaction time scores at the 
beginning and end of the test session. There was no main 
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effect for session time, indicating that the first and 
second reaction time means were not significantly different 
for both groups, F(1, 22) = .03, .2 = .86. The reaction time 
by group interaction also failed to reach significance, F(1, 
22) = .21, D = 65. There was however, a significant main 
effect for group, F(1, 22) = 4.7, D = .04, with Figure 1 
illustrating HCV participants have longer reaction times than 
controls at the beginning and end of the test session. 
Group 
Fiaure 1. Mean simple reaction times for HCV and control 
participants at the beginning and completion of the test 
session. 
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Stroop Colour-Word Task 
Word Condition: An analysis was conducted on the number 
correct data from the word condition of the Stroop task. The main 
effect of group failed to reach statistical significance, F(1, 22) 
= .10, p = .76. The same analysis was performed on the reaction 
time data for the word condition. Once again, there were no 
significant main effects for group, F(1, 22) = .21,_p = .65. 
Ink Condition: The mean number correct and reaction time 
data for the ink condition of the Stroop task was also analysed. 
In both cases, the main effect of group failed to reach 
significance [F(1, 22) = .00, p = .99 and F(1, 22) = .21, p = .65 
respectively]. 
Choice Reaction Time  
Four measures relating to choice reaction time were taken. 
These included the number of correct responses; mean thinking 
time; mean moving time; and overall mean reaction time. All were 
analysed separately using ANOVAs. There were no significant main 
effects for group [F(1, 22) = .63, 2 = .44; F(1, 22) = 2.58, .2 = 
.12; F(1, 22) = .46, il= .51; and F(1, 22) = .29, II= .60]. 
Discussion 
Small but significant differences in simple reaction 
time and perceptual-motor performance as a function of group 
(HCV/control) were found in the present research. 
HCV participants exhibited longer reaction times and 
poorer hand-eye coordination as measured in a simple reaction 
time and pursuit rotor task. Both these tasks involve 
perceptual, motor, and sustained attention components in 
order to successfully perform them. These deficits in 
performance were predicted, as glandular fever patients, with 
whom hepatitis C patients share some similarities such as 
fatigue and possible liver infection, have been found to show 
poor attention and longer reaction times when compared to 
healthy controls in previous research (Hall & Smith, 1993; 
Corney, Hale, & Ball, 1994). Whether the cognitive 
performance deficits were more associated with motor, 
perceptual or attention aspects of performance (all of which 
are tapped into by reaction time and pursuit rotor tests), 
could be examined in future HCV research by the use of tasks 
which clearly separate these functions. It is important to 
note however, that attention is not likely to be as much 
involved, as all other attention tasks such as the Stroop 
produced non-significant results. 
As HCV participants reported increased fatigue during 
viral infection, any increases in reaction time could be 
attributable to physical fatigue rather than cognitive 
20 
slowing in processes such as attention and perception. In 
order to determine whether it was the former or latter, 
reaction time performance was measured at the beginning and 
end of the test session, on the assumption that fatigue 
should have more impact on simple reaction time at the end of 
a one hour series of tests than at the beginning. No 
significant differences in reaction time between time one and 
time two were found for either group. This suggests that the 
longer reaction times of HCV participants may be cognitively 
based rather than just the greater physical fatigue reported 
by the HCV participants. 
What was perhaps surprising, however, was that reaction 
time measures during more complex tasks such as the Stroop 
colour-word task, choice reaction time and delayed 
recognition test were not significantly subject to HCV 
infection. This may suggest that it is not motor speed but 
rather a perceptual or eye-hand coordination factor measured 
in simple reaction time and pursuit tasks that is compromised 
in HCV patients, because motor speed is not deleteriously 
affected in other tasks by HCV. 
Unlike Glandular Fever patients, no impairments in 
memory were found in HCV participants, contrary to 
expectations. However, though these two viruses share some 
common symptoms, it is not surprising that they should 
produce some deficits unique to the particular virus itself. 
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With the exception of viruses that have been found to 
directly attack the brain such as HIV, evidence for 
understanding underlying mechanisms responsible for cognitive 
performance deficits resulting from viruses such as HCV is 
lacking. As mentioned previously, several hypotheses have 
been proposed, ranging from muscle fatigue (Smith, 1993), to 
the action of cytokines from the immune system (Hart, 1988; 
Dantzer et al., 1992) and to the body's reaction to the 
infection itself (Savory, 1991). Further research into the 
physiological aspects of viral infections is needed to 
elucidate the precise mechanisms involved. 
Whether the profile of deficits exhibited in HCV 
patients is unique to that virus and is replicable remains to 
be seen. It is important to recognise that there is a 
scarcity of replication in the behavioural virology area, 
resulting in a lack of independent confirmation of research 
results (Savory, 1992). Generalisations about viruses 
leading to particular impairments therefore become over 
simplified and potentially misleading. Certainly, the 
reliability of the present results would have been more 
substantial with increased participant numbers as originally 
planned, but many potential HCV participants had to be 
excluded due to concurrent viral infections and continuous IV 
drug use, all of which could have confounded results. 
Without such exclusions, the scientific value of the study 
would have been severely compromised. Regardless of this 
fact, the sample size here nevertheless compares 
satisfactorily with the number used in the majority of 
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published studies in behavioural virology (11 in Smith et 
al., 1987; and 10 in Smith et al., 1989) and was certainly 
more adequate than the amount sequestered in some previous 
behavioural virology studies (only 3 were used in Smith et 
al., 1987). 
It would be valuable for future research to compare the 
performance of a chronic HCV group of patients with that of 
acute HCV patients. Other viral research has clearly 
illustrated the importance that the variable stage or length 
of infection plays upon both the type and severity of 
cognitive impairments resulting from viral illness (Perdices, 
1994). The difficulty with this in HCV research however, is 
that few individuals realise they have HCV during the acute 
phase, as the majority are relatively asymptomatic, and this 
would be a major handicap in recruiting acute HCV patients. 
Future research may benefit from also looking at different 
levels of severity of chronic HCV, as some viral studies have 
shown that symptomatic patients tend to exhibit more 
extensive and significant deficits (Maj et al., 1994). Due 
to the limited population in Tasmania it was impossible to 
recruit a symptomatic chronic HCV group to compare to the 
primarily asymptomatic patients for the present study. In 
addition many severely symptomatic chronic patients are 
receiving interferon treatment which is known to interfere 
with cognitive functioning (Zuckerman & Thomas, 1993). 
Research into the effects of common viruses such as HCV 
is clearly beginning to provide some support for self reports 
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by those infected with viruses of decreases in their 
performance efficiency. While this may appear to be proving 
the obvious, only objective testing is capable of elucidating 
the exact nature of performance impairments that patients are 
bound to find hard to define. The findings of small but 
significant deficits in primarily simple 
motor/attention/perception tasks in HCV patients do not 
necessarily propose a serious risk for occupational safely, 
and for tasks such as driving which require these skills 
(keeping the car on the road and monitoring road signs and 
pedestrians), but it is certainly important that chronic HCV 
patients be encouraged to be more cautious and alert when 
engaging in activities that require these skills, especially 
when they themselves report increased fatigue. 
In addition, counsellors of HCV patients, tend to state 
that in order to come to terms and cope with their diagnosis, 
patients require accurate information about their illness and 
its effects, both physiological and psychological (Wilson, 
1993). Research such as the present study, can aim towards 
fulfilling the last of these requests. However, as these 
results have yet to be replicated and elaborated, assertions 
that all chronic HCV patients experience impairments in 
motor/attention skills would be premature and an 
overgeneralisation, a trap that many studies in the 
behavioural virology area fall into. 
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Appendix A 
Word lists for free recall and delayed recognition tasks. 
FREE RECALL 	DELAYED RECOGNITION 
List A 	Distractors  for list A 
price 	floor reach start scene earth drive 	stand eight stock mouth trade glass 	cause claim month fight piece share 	wrong style press dance truth break 	plant check blood spoke chief touch 	horse sight green shape doubt speed 	plane drink staff 
Appendix B 
Information sheets completed by participants. 
University of Tasmania 
DEPARTMENT OF PSYCHOLOGY 
Hepatitis C Research 
CONSENT FORM 
I consent to participate in a psychological experiment on the 
effects of chronic Hepatitis C (Hep. C), conducted by Rowena Hale 
and Peter Ball. 
I give permission to have my Hep. C status confirmed by my 
physician, my intravenous drug history known to the 
experimenter (if applicable) and to have it confirmed that I am 
not suffering from any other condition, which could interfere with 
the research results. I have fully read the information forms that 
are to be sent to my doctor. 
I have been informed that one experimental session is involved, 
lasting approximately one hour. 
I understand that each session will involve participation in 
reaction time, attention, memory, concentration, reasoning and 
hand-eye coordination tasks, administered by computer. I 
understand that my identity and my personal data will be coded 
and kept confidential by the investigator, and that I may 
withdraw from the experiment at any stage, without prejudice. I 
also understand that I may request breaks within each session, if -
I feel fatigued. 
All my questions have been answered and it has been explained 
to me that I shall be provided with extra details about the nature 
of the experiment when my participation has been completed. I 
Undertake not to divulge to any probable future participant, 
information likely to make that person ineligible to take part in 
this research. 
I agree that research data gathered for the study may be 
published, provided that I cannot be identified as a subject. 
Signature of Subject..   Date. 
I have explained this project and the implications of participation 
to this volunteer and I believe that the consent is informed and 
that he/she understands the implications of participation. 
Signature of Investigator 	  Date. 	  
Page 1. - 
Subject Number 
Testing Date 	 
Testing Time 	 
Subject Information Sheet 
Name:TArt.TI.P.LS ONLY)  
Contact Number: 	 
Gender: M/F 
Occupation: 
Years of Education: 
    
    
 
Age: 
  
   
    
     
How is your eyesight? 
How is your hearing? 	  
Have you ever used intravenous drugs, if so, what 
drugs? 
Aproximately how many times would you have used 
intravenous drugs? 
How long (approximately) since you last injected 
drugs? 
Name of a friend/relative who might act as a 
control? 
Contact number of friend/relative: 
- Page 2 - 
Could you please list the name of your GP and where 
their practice is situated? 	 
Have you experienced any physical or psychological 
symptoms as a result of your infection with 
Hepatitus C? If so, could you please list them 
below (eg. jaundice and difficulty concentrating): 
Appendix C 
ANOVAs on raw data. 
* * ANALYSIS OE VARIANCE *** 
simultaneously 
Sum of Mean Sig 
FREER 	EreeR 
by 	GROUP . 	Group 
UNIQUE sums of squares 
All effects entered 
Source of variation Squares DE Square E of E. 
Main Effects 1.500 1 1.500 .274 .606 
GROUP 1.500 1 1.500 .274 .606 
Explained 1.500 a. 1.500 .274 .606 
Residual 120.333 22 5.470 
Total 121.833 23 5.297 
24 cases were processed. 0 cases 	(.0 pct) were missing. 
* * * ANALYSIS 0 ! VARIANC3 * * * 
2URROTOR PurRotor 
by GROUP 	Group 
UNIQUE sums of squares 
All effects entered simultaneously 
	
Sum of 	Mean 	Sig 
Source of Variation 	Squares 	D7 	Square 7 	of E 
Main Effects 1363.835 1 1363.835 4.607 .043 
GROUP 1363.835 1 1163.835 4.607 .043 
Explained 1363.835 1 1363.835 4.607 - .043 
Residual 6512.754 22 296.034 
Total 7876.589 23 342.460 
24 cases were processed. 
0 cases (.0 pct) were missing. 
	 Analysis of variance 	design 1 	 - 
Tests of Between-subjects Effects. 
Tests of Significance for TI using UNIQUE sums of squares Source of variation 	SS 	DE 	MS 	F Sig of E 
WTT=TN+RESTnTIAL 22 	117 4. 4 9 GROUP 	C..00" 0.. 4 .D.14.04.01 I 	53.14.G1 • 
2 2 * 	2'Analysis 	of 	variance--design 	1 It * * IV 2 * 
Tests involving 'RT' Within-Subject Effect. 
Tests of Significance for T2 using UNIQUE sums of squares 
Source of Variation 	SS 	DE 	MS 7 Sig of 7 
WITEIN+RESTDUAL 7073.43 22 121.52 
RT 10.45 1 10.45 .03 .859 
GROUP BY RT 68.64 1 68.64 . .21 .649 
* * 	ANALYSIS or VAXIANCS * * * 
SCOLCOR SColCor 
by GROUP 	group 
urawm sums of squares 
All effects entered simultaneously 
Sum of 
Source of Variation 	 Squares 	OF 
Mean 
Square 
Sig 
F 	of F 
main Zffecte .042 1. .042 .000 	.990 
GROUP .042 1 .042 .000 	.990 
ixplftined .042 1 .042 .000 *- .990 
Residual 6045.917 22 274.814 
Total 6045.958 23 262.868 
24 case= were processed. 
0 cases (.0 pat) were missing. 
* * * ANALYSIS OF VARIANCE * * * 
SCMSANAT 
oy 	ftncur 	group 
UNIQUE sums of squares 
All effects entered simultaneously 
Sum of Mean Sig 
Source of Variation Squares OF Square F of F 
Main Effects 23732.170 1 23732.170 .208 .653 GROUP 23732.170 1 23732.170 .208 .633 
Explained 23732.170 1 23732.170 .208 .653 
Residual 2515448.549 -,-., 114338.570 
Total 2539180.720 23 1 1 0359.'62 
24 cases were processed. 
0 cases 	(.0 pct) were missing. 
* * * ANALYSIS OF VARIANCE 
sWORDCOR 
by 	GROUP 	group 
UNIQUE sums of squares simultaneously 
Sum of Mean Sig 
All effects entered 
Source of Variation Squares OF Square F of F 
Main Effects 15.042 1 15.042 .095 .760 
GROUP 15.042 1 15.042 :095 .760 
Explained 15.042 1 15.042 .095 .760 
Residual 3472.583 22 157.845 
Total 3487:625 23 151.636 
24 cases were processed. 
0 cases 	(.0 pct) were missing. 
* * * ANALYSIS OF VARIANCE * * * 
SNMEANRT 
by GROUP 	group 
UNIQUE sums of squares 
Al]. effects entered simultaneously 
Sum of Mean Sig 
Source of Variation Squares DF Square F of E 
Main Effects 16758.735 1 16758.735 .213 .649 
GROUP 16758.735 1 16758.735 .213 .649 
Explained 16758.735 1 16758.735 ;213 .649 
Residual 1728021.790 22 78546.445 
Total 1744780.525 23 75860.023 
24 cases were processed. 
0 cases (.0 pct) were missing. 
*** ANALYSIS OP VARIANCE *** 
DRCORR DRCorr 
by GROUP 	group 
UNIQUE sums of squares All effects entered simultaneously 
Source of Variation 
Sum of 
Squares DE 
Mean 
Square P 
Sig 
of E 
Main Effects 54.000 1 54.000 2.152 .157 
GROUP '54.000 1 54.000 2.152 .157 
Explained 54.000 1 54.000 2.152 .157 
Residual 552.000 22 25.091 
Total 606.000 23 26.348 
24 cases were processed. 
0 cases 	(.0 pct) were missing. 
* * * ANALYSIS OF VARIANCE * * * 
WW2 	DIRrt 
by GROUP 	group 
UNIQUE sums of squares 
All eftects entered Sim1tafleofl5l'f 
	
Sum of 	 Mean 	 Sig 
Squares 	DE 	Square F 	of F 
1.24,S4.65% 	 1.2S64•SS% 	• 31-2 • fAta. 
12084.00 1 	12064.650 .312 .582 
lingA Ccfl 	1 ,7AgA Rqn 	'1/ Art.wym.u.ov ...R.I.'. 	...PIA/. 
851522.559 	22 	38705.571 
863587.210 	23 	37547.270 
Source of Variation 
maim sttect.:5 
GROUP 
Residual 
Total 
24 cases were processed. 
0 PAtTIP 60 ppr) weo:qA ati;i74Agi, 
* * * ANALYSIS OF VARIANCE *** 
CRTCORR crtcorr 
by GROUP 	group 
UNIQUE sums of squares 
All effects entered simultaneously 
Sum of 
Source of Variation 	Squares 	DE 
Mean 
Square F 
Sig 
of 7 
Main Etta= 10B.315 , A. 1^0 .7 .7C  .V.OW 
GROUP 108.375 1 108.375 .630 .436 
Explained 108.375 1 108.375 .630 .436 
Residual 3783.583 22 171.981 
Total 3891.958 23 169.216 
24 cases Were processed. 
0 cases (.0 pct) were missing. 
* , ANALYSIS OF VARIANCE *,* 
CRTMEANY crtcorr 1711 GROUP 	group 
UNIQUE sums of squares 
All effects entered simultaneously 
Sum of Mean Sig source of Variation squares OF Square F of F 
Main Effects 30455.100 1 30455.100 2.576 .123 
GROUP 30455.100 1 30455.100 2.576 .123 
Explained 30455.100 1 30455.100 2.576 .123 
Residual 260121.967 22 11823.726 
Total 290577.067 23 12633.786 
24 cases were processed. 0 cases (.0 pct) were missing. 
m m m ANALTalti 
C2TM=ANX crtcorr DY 	e;NWUM 	group 
UNIQUE sums of squares 
All effects entered simultaneously 
Sum of' Mean Sig 
Source of Variation Squares DE Square F of F 
Hain Effects 3939.044 1 3939.844 .456 .506 
GROUP 3939.844 1 3939.844 .456 .506 
Explained 3939.844 1 3939.844 .456 .506 
Residual 189896.216 22 8631.646 
Total 193836.060 23 8427.655 
24 cases were processed. 
0 cases (.0 pct) were missing. 
C.) Y 
* * * ANALYSIS OF VARIANCE * * * 
CRTMEANR ortoorr 
by GROUP 	group 
UNIQUE sums of squares 
All effects entered simultaneously 
Sum of mean Sig 
Source of Variation Squares OF square P or P 
Main Effects 9243.375 1 9243.375 .293 .594 
GROUP 9243.375 1 9243.375 .293 .594 
Explained 9243.375 1 9243.375 .293 .594 
Residual 694340.998 22 31560.954 
Total 703584.373 23 30590.625 
24 cases were processed. 
0 cases (.0 pct) were missing. 
Appendix D 
Raw data. 
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Table 2  
Delayed Recall Raw Data for HCV and Control Participants 
HCV Participants 
Participant Mean RT No. Correct 
1 984.8 78 
2 1012.5 33 
3 925.4 2 6 
4 873.3 30 
3 832.4 37 
6 1263.2 9 
7 725.9 28 
8 747.4 78 
9 897.8 ?9 
10 847.7 30 
11 619.5 25 
12 980.2 26 
Controls 
Participant Mean RT No. Correct 
1 937.9 76 
2 748.9 30 
3 1147.6 28 
4 820.4 31 
5 983.6 33 
6 1484.0 7 8 
7 829.1 32 
8 855.6 76 
9 854.4 37 
10 1107.2 32 
11 854.8 75 
12 624.7 32 
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Table 4 
Free Recall Raw Data for HCV and Control Participants 
Participant Number of Words Recalled 
'HCV' 	'Control' 
1 3 4 
2 8 8 
3 7 4 
4 10 6 
5 9 7 
6 7 7 
7 4 6 
8 7 5 
9 3 6 
10 8 8 
11 4 5 
12 9 7 
Table 5  
Stroop Raw Data for HCV and Control Participants 
HCV partcipants 
Participant 	Word condition 	 Ink condition 
Correct Mean 
RT 
Correct Mean 
RT 
1 87 1540.1 96 1346.6 
2 84 1870.3 63 1871.7 
3 88 1484.7 98 1241.9 
4 100 977.3 98 871.5 
5 98 1156.0 96 848.6 
6 69 2115.3 61 2056.3 
7 100 1167.8 97 1004.9 
8 93 1432.2 99 867.4 
9 91 1377.4 94 1113.6 
10 97 1286.1 100 945.2 
11 90 1374.8 86 1298.4 
12 97 1106.8 97 1073.9 
Control participants 
Subject Word condition Ink condition 
Correct Mean 
RT 
Correct Mean 
RT 
1 86 1563.6 82 1241.1 
2 96 1351.4 95 1304.2 
3 93 1615.1 98 1251.2 
4 94 1247.7 94 993.0 
5 94 1343.8 99 916.7 
6 42 1862.3 31 1880.7 
7 97 1215.1 97 1097.3 
8 97 1280.4 98 834.7 
9 95 1302.2 94 1015.9 
10 96 1316.8 97 1208.3 
11 87 1004.2 89 1119.2 
12 98 1146.97 100 922.95 
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